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INTRODUCTION
Schizophrenia is a psychiatric disorder characterized by
delusions, perceptual abnormalities and deterioration of
cognitive functions resulting from diffuse gray matter
abnormalities. The disease did not gain medical
importance until the 19th century in the fields of both
psychiatry and neurology. At the end of the 20th century,
research has shown monumental discoveries regarding
the neuropathology of the disease; reduced symmetry of
the brain, changes in cerebral ventricles, limbic system,
prefrontal cortex, thalamus, basal ganglia and cerebellum
are some of the findings observed in patients with
schizophrenia.1
The lifetime risk of developing schizophrenia is between
0.7-0.9% per 1000 individuals. The point prevalence of
schizophrenia in European countries is probably
between 0.25-0.53% per 1000 individuals. Collaborative
studies of WHO have shown that prevalence of
schizophrenia, when assessed in comparable ways, is
similar in different countries. Prevalence estimate of
schizophrenia from studies in low-income countries
varies from as low as 0.8% reported from rural China to
as high as 3.8% in Sri Lanka and 5.9% in Calcutta,
India.2
A longitudinal study of brain morphology in patients with
first-episode schizophrenia established the findings of
ventricular enlargement and anterior hippocampal
volume reduction.3 Another longitudinal study, conducted
over 3 years from initial evaluation to follow-up,
concluded that there is an  accelerated enlargement in
cortical sulci in the early phase of the disease.4 They
also showed that patients with poorer outcome had a
greater enlargement of the lateral ventricles.4
Besides functional imaging for the assessment of
neurological pathways in schizophrenia, many studies
have proven that among the structural brain ab-
normalities, most consistent findings are enlarged lateral
ventricles, reduced medial temporal and prefrontal lobe
volumes.5,6 These can be assessed very well with MRI
which is the most commonly used neuroimaging
modality where available. 
There are studies on structural and functional brain
changes associated with schizophrenia which helps in
diagnosis and prognosis of the disease process.7,8
However, no such data is available regarding the
structural brain abnormalities of patients with
schizophrenia from developing countries especially
South East Asia. Therefore, this study was designed to
determine the structural brain abnormalities in patients
with schizophrenia.
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Objective: To determine structural abnormalities in the brain of patients with schizophrenia by Magnetic Resonance
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METHODOLOGY
This study was carried out collaboratively in the
Department of Radiology and Psychiatry, the Aga Khan
University Hospital, Karachi, from July 2007 to June
2008.
Thirty three patients with the ICD-10 diagnosis of
schizophrenia consented to be enrolled as cases for this
study. Patients with schizoaffective disorder or co-
morbid substance abuse, mental retardation and
organic mental disorders were excluded from the study.
We enrolled an equal number of controls. Controls were
selected from the list of patients’ referred to department
of radiology for MRI brain with non-specific symptoms;
they had no primary psychiatric or neurological disorder.
Controls were matched for the age in order to compare
the difference in the structural changes and
abnormalities. Purposive sampling was done for
induction of cases and controls to fulfill the objectives of
the study. 
The study was conducted in compliance to ethical
principles for medical research involving human
subjects’ of Helsinki Declaration and formal approval
was taken from Ethical Review Committee of the
Hospital. Written informed consent was obtained before
MRI procedure in all participants.
All patients were seen by consultant psychiatrist and
diagnosis was made according to World Health
Organization (WHO) based international classification of
disease diagnostic criteria (ICD-10). In order to measure
the onset and course of psychosis ‘Interview for
Retrospective Assessment of Age at Onset in
Schizophrenia’ was applied (IROAS).9 As part of the
protocol, all cases were given the option of free-of-cost
MRI scan through research grant.
MRI’s were obtained on a Siemens 1.5-T scanner.
Volumes of interest were acquired by using T2-weighted
scans with 1.2 mm contiguous axial slices (TE=98 msec,
TR=4000 msec, flip angle=30o, field of view=256256
mm) and single midline sagittal image was also obtained
for better delineation of corpus-callosum. Interpretation
was done on dedicated reporting console and on hard
copies. Structural brain abnormalities including atrophy,
ventricular dilatation, presence of septum pellicudum,
corpus- callosum abnormalities, prominent Virchow
Robin (VR) spaces and additional findings were
evaluated subjectively.10 Two consultant radiologists
having experience of neuroimaging made the final
report. Patients having metallic implants, pace-makers
or contraindication to MRI were excluded from the study.
Data was entered and analyzed in SPSS version 16.
Considering the brain abnormalities as an outcome of
schizophrenia the cases and controls were compared by
applying chi-square and Fisher exact test at the
statistical significance of 95% confidence level; p-value
of less than 0.05 was considered as significant.
RESULTS
There were 66 subjects, 33 were cases (16 men and 17
women) while 33 were age - matched controls (17 men
and 16 women). Mean age of male patients was 34 +
10.4 years, while for female patients it was 31 + 10
years. All patients with schizophrenia were taking
psychotropic medications and mean duration of
treatment was 10 + 9.7 months.
Most pronounced psychiatric symptoms identified on
IROAS were depressed mood (66%), worries (65%),
tension (63%), auditory hallucinations (61%), delusion
of persecution (43%), irritability (43%), sleeplessness
(43%) withdrawal/mistrust (54%), sleeplessness (43%)
and loss of self-confidence (53%). Positive symptoms of
psychosis were present in 57% subjects while negative
symptoms were present in 30% subjects.  
There was no significant gender difference between
cases and controls (Table I). Brain atrophy was the most
commonly seen structural abnormality in schizophrenia
(p=0.001), seen in 13 (39%) cases and conspicuously
absent in controls. Presence of septum pellicudum was
noted in 10 (30%) cases of schizophrenia and not seen
in any control. Prominent Virchow Robin spaces (VR)
were seen in 10 (30%) cases with schizophrenia and not
seen in any control. 
Ventricular dilatation was identified in 4 (12%) of cases
and 2 (6%) controls. Brain atrophy, presence of septum
pellicudum and prominent VR spaces were significantly
associated with schizophrenia as compared to controls
(p < 0.05). Figure 1 depicts prominent septum pellicudum
in a 25 years old male patient with schizophrenia.
Sinusitis was noted in 22 (67%) controls subjects. This
corresponded with their non-specific symptom of
headache. This corpus callosum was normal in all
patients with history of schizophrenia.
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Table I: Comparison of characteristic between cases  and controls.
variables Cases Controls Chi-square p-value
n % n %
Gender 0.061 NS
Male 16 48.5 17 51.5
Female 17 51.5 16 48.5
Brain atrophy 16.189 < 0.001
No 20 60.6 33 100
Yes 13 39.4 0 0
Ventricular dilatation - NS*
Normal 29 87.9 31 93.9
Present 4 12.1 2 6.1
Septum pellicudum 11.78 0.001
Absent 23 69.7 33 100
Present 10 30.3 0 0
Sinusitis 8.73 0.003
Absent 23 69.7 11 33.3
Present 10 30.3 22 66.7
VR spaces - < 0.001*
Non prominent 23 69.7 33 100
Prominent 10 30.3 0 0
NS = not statistically significant; *Fisher’s exact test.
DISCUSSION
This is the first study from Pakistan reporting structural
brain changes in patients with schizophrenia. In this
study, brain atrophy was identified in 39% of patients
which is consistent with an earlier study by Nelson and
Wright et al.11,12 In  the present study, this atrophy was
found to be mostly diffuse and not limited to
hippocampus or parahippocampal area alone. Cavum
septum pellucidi was noted in 30% of cases. This
frequency is lower than the earlier reports in the
literature.  Presence of cavum septum pellucidi has
been reported in 92% studies on structural brain
abnormalities on patients with schizophrenia.13,14 VR
spaces were prominent in 30% of cases, which could
very well be a non-specific finding, associated with
neuroleptics use, since most of these patients were on
medications.15 Ventricular dilatation was seen in 12% of
patients with schizophrenia and it was not significantly
different from controls. This finding is not consistent with
Shenton et al. who reported it in 80% of cases of
schizophrenia.16 Many studies have shown corpus
callosum related abnormalities associated with
schizophrenia,10-12,17 but in this study sample corpus
callosum was normal in all cases of schizophrenia. This
finding could be an artifact of small sample size as well
as absence of pediatric age patients in this sample.
In this sample, the positive and negative symptoms of
schizophrenia were assessed using IROAS, any specific
pattern of brain changes could not be identified with
symptoms-presentation. IROAS was originally developed
within the framework of the ABC (mnemonic for age,
beginning and course) schizophrenia study (Häfner et al.
1998) for systematic research on the onset of
schizophrenia.9 It is one of the most robust, widely used
instruments in the schizophrenia-research. IROAS
examines the social course, course of the symptoms,
disability and treatment from the first signs or indicators
of illness until the time of interview. There is some
evidence that regional neuropathology related to certain
symptoms of schizophrenia may be sexually dimorphic.
Cowell et al. determined for schizophrenic women that
greater frontal lobe volume was associated with more
severe disorganization and suspicious-hostility; in
schizophrenic men, smaller frontal lobe volume was
associated with more severe disorganization and did not
correlate with suspicious hostility.18
In a quantitative meta-analysis of 40 volumetric studies,
Lawrine et al. concluded that a number of differences in
brain structure were present between schizophrenic and
normal groups but there were few significant differences
between male and female schizophrenics. Their analysis
revealed that, compared to controls, schizophrenic
patients had smaller whole brain, temporal lobe and
amygdala/hippocampal complex volumes, more CSF,
larger ventricles and reduced gray matter volumes.19
Traditionally, schizophrenia is divided in to five sub-types
based on the phenomenological symptoms. This
categorization does have its utility in being able to
predict treatment and prognosis. However, the major
stumbling block for researchers may be the definition of
disease phenotype. Though the classical clinical picture
of schizophrenia based on delusions and hallucinations
can be vivid, one contributing factor to the failure to
identify a susceptible gene and uncovering the etiology
of schizophrenia, may be that classical symptoms-
based disease phenotype is too narrowly defined and
too heterogeneous and, classical disease phenotype
are not stable over time. This problem led many
researchers to propose employment of heritable
neurobiological traits correlated with the disease as the
phenotype. Such intermediate or endo-phenotypes,
sometimes referred as biomarkers, are proposed to
have simplistic utility, improved operational definitions,
and for some, more objective diagnosis.20
Although this proposition is still in its infancy, an
emerging consensus among investigators is that the
most useful candidate biological marker for
schizophrenia are those that are more frequent in
patients than control population; that are stable over
time and insensitive to age, gender, and medication
status; that are more frequent in non-schizophrenic
members of multiply affected families than control
populations. Possible candidates for biological markers
include abnormalities on structural neuro-imaging and
cognition (impairment in attention).21 One of the
applications of this study is that it serves to establish the
presence of structural brain changes as an endo-
phenotype in a sample of patients with schizophrenia.
This could pave the way for further research on the
etiology of this disorder. 
There were several limitations to this study. The relatively
small study sample, subjective assessment of finding and
screening MRI might have limited the ability to find the
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Figure 1:  T2W axial Image showing prominent cavum septum pellicudum in
25 years old male patient of schizophrenia.
 
spectrum of ventricular dilation and brain atrophy across
the full range of patients with schizophrenia. Additionally,
there was no assessment of inter-observer agreement
amongst the radiologist for interpretation of MRI. 
Patients were enrolled with diagnosis of schizophrenia
already being treated. Since their previous imaging was
unavailable for comparison, causal association of
schizophrenia with observed brain changes cannot be
assessed, some of the observed findings may be an
effect of the neuroleptic medicines. Understanding the
complexity of schizophrenia regarding the diagnosis and
treatment is studied in a detailed manner by functional
and anatomical imaging, mainly by MRI. Larger
longitudinal studies with functional imaging are required
in order to establish the association between
schizophrenia and structural abnormalities of brain.
CONCLUSION
Brain atrophy and presence of septum pellicudum were
commonly associated structural brain changes in
patients with schizophrenia. MRI is a useful and
accurate modality in identifying these structural brain
changes and can be used in the diagnosis and
prognosis of patients with schizophrenia.
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